B2UXC6 AF NFT

Glutamyl-tRNA reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeibc22tqqsj4puwron5bknwuvbbb7shkkj2k6mmysbmjilpnto2rve/metadata.json
IPFS of structure file: 
bafybeihzvsaqwrqlrdxdqdkxhd7yqcbedfyxa5ua5kp4skjviy3qjqgnb4/AF-B2UXC6-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x17929714e8AC933ecd9259e972Ac1d436713b8a9
First NFT owner address (bech32): 
genesis1z7ffw98g4jfnanvjt85h9tqagdn38w9ftlxt4c
Current NFT ID #166550 owner (web3): 

0xE98bd0722a8eEb0377b675F85e9ceBC2DbC988D6

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
166550
Accession (UniProt):
B2UXC6
Name::
Glutamyl-tRNA reductase
Experimental Method:
Predicted structure
Sequence source:
CLOSTRIDIUM BOTULINUM (STRAIN ALASKA E43 / TYPE E3)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2UXC6 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2UXC6|HEM1_CLOBA Glutamyl-tRNA reductase OS=Clostridium botulinum (strain Alaska E43 / Type E3) OX=508767 GN=hemA PE=3 SV=1 MIAVLGIKRNTPIEIREKLTIKANKHDEYLDRLLKYLDGVIILATCNRTEIYFNVSFINEELLKKIFEIFNWNYSYRKYIFISEDKKACKHLFEVTCGFHSKILGEDQILGQVKTSYFKSLNAKALNLELQRLFQYAITCGKKFKSQSRLFEIPVSSASIVVNESINKDCKKFMVLGYGDVGRLTMKYLLAHNINEVYLAVRNKKIKDEIVDERVNVIDFEEKNKYINDMDCVISCTSAPHIVIKKQDINNIGDNILIYDLAVPRDVDDEINDIDRAQVYNIDNISYINDGNKKMRFDKMDSNKFILENYLNEYYEWKRLRSIAPFIEELKVTSKEIYDKRITTFKNKCKYRGDVDLANKMIKSTSDYYMNRAIEIMKEETLKGSEEECLRIIKSIFIAKK

We use cookies on this site to enhance your user experience

By clicking the Accept button, you agree to us doing so.